Previous Close | 17.9 |
1-Year Change | -76.59% |
6-Months Change | -44.87% |
3-Months Change | -3.97% |
Moving Avg (50d) | 18.729 |
Moving Avg (200d) | 30.164 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 195.0M |
Beta (3-Years) | 0.94 |
Revenue Growth (ttm) | -29.8% |
Net Profit Margin (ttm) | 11.86% |
Return On Assets (ttm) | 37.47% |
EPS (ttm) | 10.99 |
PE Ratio (ttm) | 1.63 |
Dividend Yield | 36.82% |
Asset Description: | Medifast, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2023-02-23 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
104.458 | 101.26 | 99.129 | 95.931 | 90.601 | 85.272 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.